Navigation Links
Bioreactor for bone tissue engineering wins professor venture fair
Date:11/19/2009

COLLEGE PARK, Md.-John Fisher, associate professor in the Fischell Department of Bioengineering, won the Best Inventor Pitch at the 2009 Bioscience Research and Technology Review Day with a tissue engineering bioreactor system that grows bone and other types of tissue for implantation.

Fisher's technology was one of six innovations presented in an eight minute pitch by faculty members and graduate students at the Professor Venture Fair, held November 12 at the University of Maryland.

"Dr. Fisher impressed the judges with his clearly defined product-the bioreactor system itself-and his ability to position himself within an already vibrant tissue engineering marketplace," says Gayatri Varma, executive director of the university's Office of Technology Commercialization.

Fisher's novel, patent-pending bioreactor system makes tissue engineering more efficient by addressing many of the shortcomings of available systems, such as the high cost and complexity of the perfusion chamber and the low output of the rotating flask. His approach exposes growing tissue to an increased amount of oxygen and nutrients, making it a more prolific and cost effective bioreactor than those currently on the market.

Fisher, along with graduate student researcher Andrew Yeatts and undergraduate student researcher Elyse Geibel, both from the Fischell Department of Bioengineering, have already created a prototype in the lab using off-the-shelf products. Fisher plans to start a company to bring the bioreactors to a commercial market.

"We're thrilled to win the Best Inventor Pitch for Bioscience Day 2009," says Fisher. "It is a fantastic opportunity to be able to describe our work and concept to local venture capitalists. We hope to use this award as a springboard to launch our company, ProlifiTEC." Other technologies presented include:

  • "Nanolithography with Nanowire Arrays," John Fourkas, Millard Alexander Professor and Associate C
    '/>"/>

Contact: Eric Schurr
schurr@umd.edu
301-405-3889
University of Maryland
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor
2. ExcellGene and Khner achieved milestone in development of novel 250 Liter mammalian cell culture bioreactors
3. Novel bioreactor enhances interleukin-12 production in genetically modified tobacco plants
4. For young boys with cancer, testicular tissue banking may be option to preserve fertility
5. A major step in making better stem cells from adult tissue
6. National Institutes of Health award Clemson $9.3 million for tissue regeneration center
7. KINAXO launches KinAffinity services for efficient profiling of kinase inhibitors in cells or tissue
8. University of Miami receives NIH grant to support novel technology for tissue engineering
9. Green tea component may help preserve stored platelets, tissues
10. Researcher says microchannels could advance tissue engineering methods
11. Skin-like tissue developed from human embryonic stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... by Northwestern Medicine® scientists helps explain how bipolar disorder ... new drug therapies to treat the mental illness. ... the same method recognized with the 2014 Nobel ... brain tissue from mice with bipolar-like behaviors. In the ... tiny "nanodomain" structures with concentrated levels of ANK3 -- ...
(Date:10/18/2014)... and stress-related psychiatric disorders are associated with ... molecular mechanisms underlying this relation are unknown. ... development of targeted preventive strategies and new ... This work is presented at the European ... an international group of researchers from Germany ...
(Date:10/17/2014)... Copenhagen have shown for the first time how bacteria ... patients, giving them the opportunity to get tremendous insights ... The study also discovered the bacterial growth in chronic ... or slowed down by the immune cells. The researchers ... helped "suffocate" the bacteria, forcing the bacteria to switch ...
Breaking Biology News(10 mins):Bipolar disorder discovery at the nano level 2Researchers find why depression and aging linked to increased disease risk 2Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2
... million years ago, when the lineage of humans and ... turnips may have been one of the reasons. According ... of Minnesota and Richard Wrangham of Harvard University, the ... tubers must have sustained our ancestors who left the ...
... all likely to blame for poisoning the waters being drained from ... is leaving behind -- also owes its contamination to a source ... environments that made their way en masse into the water as ... Florida professor who has spent years studying the harmful contaminants that ...
... other non-terminal, debilitating conditions and diseases is both feasible ... such test on the approach in patients with advanced ... edition of the Proceedings of the National Academy of ... the potential to block the destructive inflammation process that ...
Cached Biology News:The roots of civilization trace back to ... roots 2Toxic flood lifts lid on common urban pollution problem 2Toxic flood lifts lid on common urban pollution problem 3Results of world's first gene therapy trial for arthritis show approach safe, feasible 2Results of world's first gene therapy trial for arthritis show approach safe, feasible 3Results of world's first gene therapy trial for arthritis show approach safe, feasible 4
(Date:10/25/2014)... 24, 2014 This research report ... Starch Based Plastics, Regenerated Cellulose, PCL), by Application ... and Forecasts to 2019”, defines and segments the ... forecast of its global volume and value. , ... spread through 178 Slides and in-depth TOC on ...
(Date:10/25/2014)... SonaCare Medical, LLC, leader in ... announced that its Board of Directors has appointed ... President and member of the Board effective immediately. ... expanded responsibilities within the company, including further developing ... commercialization, manufacturing and finance. , Dr. Carol ...
(Date:10/25/2014)... Great Barrington, MA (PRWEB) October 25, 2014 ... contamination control products, is pleased to announce the ... to achieve the highest level of contamination containment ... in ISO Class 3 and higher cleanroom environments, ... continuous filament polyester knit laundered wiper that continues ...
(Date:10/25/2014)... NEW YORK , Oct. 24, 2014 ... Access Pharmaceuticals, Inc. (ACCP), a biopharmaceutical company advancing ... implemented a 1-for-50 reverse split of its common ... Friday, October 24, 2014. PlasmaTech,s common stock will ... number 72754H109 and temporary ticker symbol "ACCPD". After ...
Breaking Biology Technology:Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 2Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 3Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 4SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 3Ions Are Bygones, Berkshire Announces the Release of New Innovative Cleanroom Wipers 2PlasmaTech Biopharmaceuticals, Inc. Announces Reverse Stock Split, Ticker Change and Launches New Corporate Website 2
... April 8 ImQuest Life Sciences presented their ... their novel small molecule piperazine compound for the ... Therapeutics meeting held in Whistler, British Columbia. The ... lead microtubule inhibitor, IQP-0304. The piperazines demonstrate potent ...
... 8 Micromet, Inc. (Nasdaq: MITI ... for the treatment of cancer, inflammation and autoimmune ... the peer-reviewed Journal of Immunotherapy (1) demonstrating the ... to carcinoembryonic antigen (CEA) and to CD3 on ...
... 7 Pharmatech Oncology, Inc., a Research Management Organization ... companies at the Company Showcase during BIOZONA 2009 - ... Downtown on April 7th in Phoenix, Arizona.Matthew B. Wiener, ... during the first session of the conference. The ...
Cached Biology Technology:ImQuest Presentation at Keystone Symposium Focuses on Advancements in Their Cancer Research and Development Program 2Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth 2Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth 3Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth 4Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA 2
MAb to Vasopressin Preservative: NaN3...
... Anti-AP-2 α, clone 8G8/5 GenBank Accession ... made human AP-2alpha/gamma fusion protein corresponding to ... 278-450 of human AP-2γ Formulation: 0.1M Tris-glycine, ... before the addition of glycerol to 30% ...
Mouse monoclonal [1C6/2] to Rad17 ( Abpromise for all tested applications). entrezGeneID: 5884 SwissProtID: Q9UPF5...
MMP-2 / MMP-9 Inhibitor IV is a potent, selective, slow binding and mechanism based inhibitor of human gelatinases. • Molecular weight: 306.4 • Molecular Formula: C(15)H(14)O(3)S(2). &bul...
Biology Products: